• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Infectious Disease Immunoassays

$2,800.00 – $5,600.00

Clear
SKU: KLI15498315 Categories: Diagnostics Market Research, Immunoassays Pages: 180
  • Description
  • Table of Contents
  • Latest reports

Description

World Market for Infectious Disease Immunoassays

This report contains important business data for the infectious disease immunoassay, market, a high-growth area of immunoassy IVD testing. The report contains: Global Lab-based Infectious Disease Immunoassay Market Sizing for the following infection types:

  • Hepatitis
  • HIV
  • STD
  • TORCH
  • Respiratory
  • HAIs
  • Other Infectious Disease
Kalorama Information’s report, The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion. The following are among the data provided in the report:
  •  Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease (in millions$))
  •  Global Lab-based Infectious Disease Immunoassay Market Share % 2016
  •  Lab-Based Immunoassay Market by Geographic Region 2021
  •  POC Infectious Disease Immunoassay Market
  •  Lab-Based Immunoassay Infectious Disease Market by Country (US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
  •  POC Infectious Disease Immunoassay Market by Country(US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
  •  Trends and Information
  •  Corporate Profiles
 
Some infectious disease immunoassays are being replaced with molecular assays. For example, most chlamydia and gonorrhea testing in developed countries is performed with molecular diagnostic assays rather than with immunoassays. A major driving factor in this conversion to molecular testing for chlamydia and gonorrhea was the increased sensitivity of these molecular tests compared to traditional immunoassays, and especially compared to traditional rapid tests such as lateral flow-based assays. However, many improvements have been made with immunoassays to improve the technical performance of these assays, including better sensitivity. Innovations in immunoassay technology and platforms have been discussed in Chapter 4, and many companies developing these new, innovative platforms are profiled in this report.
A key area of immunoassay testing is in detecting infectious diseases.  The infectious disease immunoassay market is large because of the many different infectious agents affecting the population.  Common infectious disease immunoassays performed in central laboratories are typically categorized into groups such as hepatitis, retroviral testing, sexually transmitted diseases, TORCH, and other infectious diseases. Infectious disease immunoassays are used in point-of-care setting or when rapid testing is needed. Immunoassays are also used to screen blood and blood products in order to prevent transfusion-transmitted infections.  
 
Companies involved in the infectious disease immunoassay market include:
  • Accubiotech Co, Ltd.
  •  Alere Inc
  •  Arkray, Inc
  •  Arlington Scientific, Inc.
  •  Atlas Link Biotech Co., Ltd
  •  Beckman Coulter, Inc
  •  Becton Dickinson (Bd)
  •  Biokit S.A.
  •  Biomerieux Sa
  • Bio-Rad Laboratories Inc
  • Bioscan Screening Systems, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Diasource Immunoassays Sa
  • Elitechgroup, Inc.
  • Erba Diagnostics, Inc.
  • Grifols International S.A.
  • Hema Diagnostic Systems, Llc
  • Labsystems Diagnostics Oy
  • Luminex Corporation
  • Medix Biochemica
  • Medmira, Inc
  • Meridian Bioscience, Inc
  • Nano-Ditech Corporation
  • Novatec Immunodiagnostica Gmbh
  • Oncimmune Holdings Plc.
  • One Lambda
  • Operon
  • Orasure Technologies, Inc.
  • Quidel Corporation
  • Response Biomedical Corp
  • Savyon Diagnostics Ltd.
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Standard Diagnostics, Inc.
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc
  • Trinity Biotech Plc
  • Wako Diagnostics

Table of Contents

1: EXECUTIVE SUMMARY

OVERVIEW

Table 1-1: Infectious Disease Immunoassay Sales

SCOPE AND METHODOLOGY

FUTURE PROSPECTS IN THE INFECTIOUS DISEASE IMMUNOASSAY MARKET

2: INTRODUCTION

HISTORY AND FUTURE OF IMMUNOASSAYS

POINT OF VIEW

ELISA

Radioimmunoassays

OVERVIEW – INSTRUMENT PLATFORMS

Automation

Platform Innovations – Miniaturization, Microfluidics and Multiplexed Assays

SPECIMEN TYPES

  • Blood
  • Urine
  • Saliva

Table 2-1: Selected Companies with Saliva or Oral-Fluid Collection Devices

RAPID AND POINT-OF-CARE TESTING

  • POC Testing in Hospitals
  • Physician’s Office Laboratories and Clinics
  • Retail Clinics
  • Other Professional POC Testing
  • Self-Testing

IMMUNOASSAY MARKET – MARKET DRIVERS AND CHANGES

EMERGING INTERNATIONAL MARKETS

Table 2-2: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays

OUTLOOK FOR IMMUNOASSAYS

Table 2-3: Selected Infectious Disease Immunoassays

Table 2-4: Selected Companies Marketing Immunoassasys for Infectious Disease

3: INFECTIOUS DISEASE IMMUNOASSAYS MARKET ANALYSIS

INFECTIOUS DISEASE

  • Hepatitis
  • Retroviral
  • Sexually Transmitted Diseases
  • TORCH
  • Other Infectious Diseases –Immunoassays in Central Laboratories
  • Rapid and POC Testing
  • Blood Testing

LAB-BASED INFECTIOUS DISEASE IMMUNOASSAY MARKET BY DISEASE

Table 3-1: Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other

Infectious Disease (in millions$))

Figure 3-1: Global Lab-based Infectious Disease Immunoassay Market Share % 2016

Table 3-2: Lab-Based Immunoassay Market by Geographic Region 2021

POINT OF CARE/RAPID TEST IMMUNOASSAYS

Table 3-3: POC Infectious Disease Immunoassay Market

MARKET BY COUNTRY – LAB-BASED

Table 3-4 Lab-Based Immunoassay Infectious Disease Market by Country (US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi

Arabia, Turkey, Canada)

MARKET BY COUNTRY-POINT OF CARE

Table 3-5: POC Inectious Disease Immunoassay Market by Country

4: COMPANY PROFILES

ABBOTT

Table 4-2: Abbott Corporate Summary

Company Overview

Product

Company Financials

Table 4-2: Abbott Laboratories Revenue (2013-2016) ($ millions)

ACCUBIOTECH CO, LTD.

Table 4-3: AccuBioTech Summary

Company Overview

Products

ALERE INC

Table 4-4: Alere Corporate Summary

Company Overview

Product

Company Financials

Table 4-5: Alere Revenue (2013-2016) ($ millions)

ARKRAY, INC

Table 4-6: ARKRAY Corporate Summary

Company Overview

Products

ARLINGTON SCIENTIFIC, INC.

Table4-7: Arlington Scientific Corporate Summary

Company Overview

Products

ATLAS LINK BIOTECH CO., LTD

Table 4-8: Atlas Link Biotech Summary

Company Overview

Products

BECKMAN COULTER, INC

Table 4-9: Beckman Coulter Corporate Summary

Company Overview

Products

Company Financials

Table 4-10: Beckman Coulter (2013-2016) ($ millions)

BECTON DICKINSON (BD)

Table 4-11: BD Corporate Summary

Company Overview

Products

Company Financials

Table 4-12: BD (2013-2016) ($ millions)

BIOKIT S.A.

Table 4-13: Biokit Corporate Summary

Company Overview

Products

BIOMERIEUX SA

Table 4-14 bioMerieux SA Corporate Summary

Company Overview

Products

Company Financials

Table 4-15: bioMerieux Revenues (2013-2016) ($ millions)

BIO-RAD LABORATORIES INC

Table 4-16: Bio-Rad Labs Corporate Summary

Company Overview

Products

Company Financials

Table 4-17: Bio-Rad Labs (2013-2016) ($ millions)

BIOSCAN SCREENING SYSTEMS, INC.

Table 4-18: Bioscan Screening Systems Corporate Summary

Company Overview

Products

CHEMBIO DIAGNOSTIC SYSTEMS, INC.

Table 4-19: Chembio Diagnostic Corporate Summary

Company Overview

Products

Company Financials

Table 4-20: Chembio Diagnostics Revenues (2013-2016) ($ millions)

DIASOURCE IMMUNOASSAYS SA

Table 4-21: Diasource ImmunoAssays Corporate Summary

Company Overview

Products

ELITECHGROUP, INC.

Table 4-22: ELITechGroup Corporate Summary

Company Overview

Products

ERBA DIAGNOSTICS, INC.

Table 4-23: ERBA Diagnostics Corporate Summary

Company Overview

Products

Company Financials

Table 4-24: ERBA Diagnostics (2013-2016) ($ millions)

GRIFOLS INTERNATIONAL S.A.

Table 4-25: Grifols International S.A. Corporate Summary

Company Overview

Products

Company Financials

Table 4-26: Grifols (2013-2016) ($ millions)

HEMA DIAGNOSTIC SYSTEMS, LLC

Table4-27: Hema Diagnostics Systems Corporate Summary

Company Overview

Products

LABSYSTEMS DIAGNOSTICS OY

Table 4-28: Labsystems Diagnostics Corporate Summary

Company Overview

Products

LUMINEX CORPORATION

Table 4-29: Luminex Corporate Summary

Company Overview

Products

Company Financials

Table 4-30: Luminex (2013-2016) ($ millions)

MEDIX BIOCHEMICA

Table 4-31: Medix Biochemica Summary

Company Overview

Products

MEDMIRA, INC

Table 4-32: MedMira Corporate Summary

Company Overview

Products

Company Financials

Table 4-33: MedMira. (2013-2016) ($ millions)

MERIDIAN BIOSCIENCE, INC

Table 4-34: Meridian BioScience Corporate Summary

Company Overview

Products

Company Financials

Table 4-35: Meridian Bioscience Revenue (2013-2016) ($ millions)

NANO-DITECH CORPORATION

Table 4-36: Nano-Ditech Corporate Summary

Company Overview

Products

NOVATEC IMMUNODIAGNOSTICA GMBH

Table 4-37: Novatec Immunodiagnostica Corporate Summary

Company Overview

Products

ONCIMMUNE HOLDINGS PLC.

Table 4-38: Oncimmune Corporate Summary

Company Overview

Products

Company Financials

Table 4-39: Oncimmune Revenue (2013-2016) ($ millions)

ONE LAMBDA

Table 4-40: One Lambda Corporate Summary

Company Overview

Products

OPERON

Table 4-41: Operon Corporate Summary

Company Overview

Products

ORASURE TECHNOLOGIES, INC.

Table 4-42: OraSure Technologies Corporate Summary

Company Overview

Products

Company Financials

Table 4-43: OraSure Revenue (2013-2016) ($ millions)

QUIDEL CORPORATION

Table 4-44: Quidel Corporate Summary

Company Overview

Products

Company Financials

Table 4-45: Quidel Revenue (2013-2016) ($ millions)

RESPONSE BIOMEDICAL CORP

Table 4-46: Response Biomedical Corporate Summary

Company Overview

Products

Company Financials

Table 4-47: Response Biomedical Revenue (2013-2016) ($ millions)

SAVYON DIAGNOSTICS LTD.

Table 4-48: Savyon Diagnostics Summary

Company Overview

Products

SEKISUI DIAGNOSTICS

Table 4-49: Sekisui Diagnostics Summary

Company Overview

Products

SIEMENS HEALTHINEERS

Table 4-50: Siemens Healthineers Corporate Summary

Company Overview

Products

Company Financials

Table 4-51: Siemens Healthineers Revenue (2013-2016) ($ millions)

STANDARD DIAGNOSTICS, INC.

Table 4-52: Standard Diagnostics Corporate Summary

Company Overview

Products

TECO DIAGNOSTICS

Table 4-53: Teco Diagnostics Corporate Summary

Company Overview

Products

THERMO FISHER SCIENTIFIC, INC

Table 4-54: Thermo Fisher Scientific Corporate Summary

Company Overview

Products

Company Financials

Table 4-55: Thermo Fisher Scientific (2013-2016) ($ millions)

TRINITY BIOTECH PLC

Table 4-56: Trinity Biotech Corporate Summary

Company Overview

Products

Company Financials

Table 4-57: Trinity Biotech Revenue (2013-2016) ($ millions)

WAKO DIAGNOSTICS

Wako Life Sciences

Table 4-58: Wako Diagnostics Corporate Summary

Company Overview

Products

    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025

Related products

  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    $1,995.00 – $3,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Market for Laboratory-Developed Tests: Services (Labs Performing...The Global Market for Medical Devices, 8th Edition (40 Specific Device Markets...
Scroll to top